What is it about?
Objective: A systematic review was performed to evaluate if the use of botulinum toxin was able to reduce the intensity of myofascial pain compared to other treatments in adult patients. Material and Methods: A comprehensive search was carried out in the MEDLINE via Pub-Meb, Scopus, Web of Science, LILACS, BBO and Cochrane Library. In addition, the gray literature was also researched. The risk of bias tool from the Cochrane Collaboration was used by two independent reviewers for quality assessment of the studies.
Featured Image
Photo by Diana Polekhina on Unsplash
Why is it important?
The BTX-A reduced the intensity of myofascial pain compared to saline solution in adults after 3 months. However, further studies should be conducted to corroborate this finding. Keywords: Meta-analysis; Myofascial Pain Syndromes; Botulinum Toxins.
Perspectives
The BTX-A reduced the intensity of myofascial pain compared to saline solution in adults after 3 months. However, further studies should be conducted to corroborate this finding. Keywords: Meta-analysis; Myofascial Pain Syndromes; Botulinum Toxins.
Acquire Publications
Read the Original
This page is a summary of: Does the Use of Botulinum Toxin Reduce the Intensity of Myofascial Pain in Adult Patients? A Systematic Review and Meta-Analysis, Journal of Dentistry and Oral Epidemiology, November 2021, Acquire Publications LLC,
DOI: 10.54289/jdoe2100107.
You can read the full text:
Resources
Contributors
The following have contributed to this page
